Literature DB >> 26559393

Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis.

E Galli-Novak1, S-C Mook1,2, J Büning3, E Schmidt1,4, D Zillikens1, D Thaci2, R J Ludwig1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26559393     DOI： 10.1111/jdv.13499

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  11 in total

Review 1.  Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review.

Authors:  Javier P Gisbert; María Chaparro
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

Review 2.  Oversight and Management of Women with Psoriasis in Childbearing Age.

Authors:  Ștefana Bucur; Alexandra-Petruța Savu; Ana Maria Alexandra Stănescu; Elena-Daniela Șerban; Alin-Codruț Nicolescu; Traian Constantin; Anca Bobircă; Maria-Magdalena Constantin
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

Review 3.  The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.

Authors:  May Ching Soh; Marcelo Moretto
Journal:  Obstet Med       Date:  2019-05-30

Review 4.  Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors:  Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal:  Clin Exp Gastroenterol       Date:  2017-11-15

Review 5.  Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.

Authors:  C Venturin; S Nancey; P Danion; M Uzzan; M Chauvenet; C Bergoin; X Roblin; B Flourié; G Boschetti
Journal:  BMC Gastroenterol       Date:  2017-06-19       Impact factor: 3.067

6.  Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Sailish Honap; Susanna Meade; Hajir Ibraheim; Peter M Irving; Michael P Jones; Mark A Samaan
Journal:  Dig Dis Sci       Date:  2021-03-16       Impact factor: 3.199

7.  The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU.

Authors:  María Chaparro; María G Donday; Francisco Abad-Santos; Francisco Javier Martín de Carpi; Miguel Ángel Maciá-Martínez; Dolores Montero; Diana Acosta; Yanire Brenes; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2021-06-03       Impact factor: 4.409

Review 8.  A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases.

Authors:  Hang Hock Shim; Pak Wo Chan; Sai Wei Chuah; Brian J Schwender; San Choon Kong; Khoon Lin Ling
Journal:  JGH Open       Date:  2018-06-20

9.  Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease.

Authors:  Ioanna Aggeletopoulou; Stelios F Assimakopoulos; Christos Konstantakis; Christos Triantos
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

10.  Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review.

Authors:  N Ghalandari; R J E M Dolhain; J M W Hazes; E P van Puijenbroek; M Kapur; H J M J Crijns
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.